glp-1 intracranial hypertension Treatment with receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic | The Journal of Headache and Pain Effect of glucagon like peptide-1

Across SELECT, FLOW, and SURMOUNT outcome data, cardiovascular and kidney effects appear net positive over multi-year follow-up

This selective clearance reduces the accumulation of senescent cells, restores tissue homeostasis, and supports cell cycle regulation

Due to its pleiotropic effect on the brain, pancreas, gastrointestinal tract and muscle, promotes an overall metabolic improvement rising lipolysis, fatty acid oxidation, ketogenesis and blocking hepatic de novo lipogenesis, overexpression of LDL receptor promoting a decline in LDL-cholesterol levels, and increasing energy expenditure to promote diabetes control and weight loss

Risks and Challenges While the outlook is promising, investors must consider several potential challenges: 1